Variability in meta-analytic results concerning the value of cholesterol reduction in coronary heart disease: A meta-meta-analysis

American Journal of Epidemiology

Volumn 149, Issue 5, 1999, Pages 429-441

  Katerndahl, David A ^a   Lawler, W Ross ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiovascular diseases; Hypercholesterolemia; Meta analysis; Research design

Indexed keywords

CHOLESTEROL;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL RESEARCH; DATA ANALYSIS; DATA BASE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; STATISTICAL ANALYSIS;

EID: 0033105802     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009830     Document Type: Article

References (57)

1. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.
2. Consensus conference. Lowering blood cholesterol to prevent heart disease. JAMA 1985;253:2080-6.
3. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 1987;8:77-88.
4. The British Cardiac Society Working Group on Coronary Prevention: conclusions and recommendations. Br Heart J 1987;57:188-9.
5. Shepherd J, Betteridge DJ, Durrington P, et al. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines for the British Hyperlipidemia Association. BMJ 1987;295:1245-6.
6. Report of the National Cholesterol Education Program Expert Panel. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med 1988;148:36-69.
7. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-14.
8. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992;305:15-19.
9. Ravnskov U. Frequency of citation and outcome of cholesterol lowering trials. (Letter). BMJ 1992;305:717.
10. US Congress, Office of Technology Assessment. Identify health technologies that work: searching for evidence. Washington, DC: US Government Printing Office, 1994. (Publication no. OTA-H-608).
11. O'Brien PC. Meta-analysis. (Editorial). Mayo Clin Proc 1993;68:91-3.
12. Michels KB. Quo vadis meta-analysis? A potentially dangerous tool if used without adequate rules. Important Adv Oncol 1992:243-8.
13. Bero L, Rennie D. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA 1995;274:1935-8.
14. Mosteller FM, Tukey JW. Data analysis including statistics. In: G Lindzey, E Aronson, eds. Handbook of social psychology. 2nd ed. Reading, MA: Addison-Wesley, 1968.
15. Sacks HS, Berner J, Reitman D, et al. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450-5.
16. Berlin JA. Randomized trial comparing masked/unmasked meta-analysis. Washington, DC: Agency for Health Care Policy and Research, 1998. (Publication no. PB98-109382).
17. Spitzer WO. Meta-meta-analysis. (Editorial). J Clin Epidemiol 1991;44:103-7.
18. Thompson SG, Pocock SJ. Can meta-analyses be trusted? Lancet 1991;338:1127-30.
19. Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer. J Clin Epidemiol 1991;44:127-39.
20. Detsky AS, Naylor CD, O'Rourke K, et al. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992;45:255-65.
21. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991;44:1271-8.
22. Oxman AD, Guyatt GH, Singer J, et al. Agreement among reviewers of review articles. J Clin Epidemiol 1991;44:91-8.
23. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. JAMA 1995;273:408-12.
24. Light R, Pillemer D. Summing up. Cambridge, MA: Harvard University Press, 1984.
25. Hedges LV. Modeling publication selection effects in meta-analysis. Stat Sci 1992;7:246-55.
26. Garfield E. Which medical journals have the greatest impact? Ann Intern Med 1986;105:313-20.
27. Henry DA, Wilson A. Meta-analysis. Part 1 : An assessment of its aims, validity and reliability. Med J Aust 1992;156:31-8.
28. Chalmers TC, Levin H, Sacks HS, et al. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. Stat Med 1987;6:315-28.
29. Chalmers TC, Berrier J, Sacks HS, et al. Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree. Stat Med 1987;6:733-44.
30. McConaghy N. Can reliance be placed on a single meta-analysis? Aust N Z J Psychiatry 1990;24:405-15.
31. Searles JS. Methodological and empirical critique of psychotherapy outcome meta-analysis. Behav Res Ther 1985;23:453-63.
32. Cappelleri JC, Ioannidis JPA, Schmid CH, et al. Large trials vs. meta-analysis of smaller trials. JAMA 1996;276:1332-8.
33. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995;142:371-82.
34. Berlin JA. Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies. Am J Epidemiol 1995;142:383-7.
35. Cook DJ, Reeve BK, Heyland DK, et al. Stress ulcer prophylaxis in critically ill patients. JAMA 1996;275:308-14.
36. McGeer AJ, Naylor CD, O'Rourke K, et al. Study quality as a factor in meta-analysis. (Abstract). Clin Res 1989;37:320A.
37. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6.
38. Katerndahl DA, Realini JP, Cohen PA. Oral contraceptive use and cardiovascular disease. J Fam Pract 1992;35:147-57.
39. Glass GV, McGaw B, Smith ML. Meta-analysis of social research. Beverly Hills, CA: Sage Publications, 1981.
40. Ingelfinger JA, Mosteller F, Thibodeau LA, et al. Biostatistics in clinical medicine. 3rd ed. New York, NY: McGraw-Hill, 1994.
41. Assendelft WJJ, Koes BW, Knipschild PG, et al. Relationship between methodologic quality and conclusions in reviews of spinal manipulation. JAMA 1995;274:1942-8.
42. Jadad AR, McQuay HJ. Meta-analyses to evaluate analgesic interventions. J Clin Epidemiol 1996;49:235-43.
43. Silberberg JS, Henry DA. Benefits of reducing cholesterol levels. Med J Aust 1991;155:665-70.
44. Alberts MJ, Goldstein LB, Smith T. Guidelines on the use of thrombolytic agents in stroke. (Letter). JAMA 1995;274:217-18.
45. Peto R. Why do we need systematic overviews of randomized trials? Stat Med 1987;6:233-40.
46. Chalmers TC. Problems induced by meta-analyses. Stat Med 1991;10:971-80.
47. Horwitz RI. Complexity and contradiction in clinical trial research. Am J Med 1987;82:498-510.
48. Rosenthal R. Experimenter effects in behavioral research. New York, NY: Irvington Publishers, 1976.
49. Chalmers TC, Frank CS, Reitman D. Minimizing the three stages of publication bias. JAMA 1990;263:1392-5.
50. Dickersin K. Existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-9.
51. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data. Lancet 1993;341:418-22.
52. Simes RJ. Confronting publication bias. Stat Med 1987;6:11-29.
53. Smith ML. Publication bias and meta-analysis. Eval Educ 1980;14:22-4.
54. Detsky AS, Baker JP, O'Rourke K, et al. Perioperative parenteral nutrition. Ann Intern Med 1987;107:195-203.
55. Sherer RW, Dickersin K, Langenberg P. Full publication results initially presented in abstracts. JAMA 1994;272:158-62.
56. Cook DJ, Guyatt GH, Ryan G, et al. Should unpublished data be included in meta-analyses? JAMA 1993;269:2749-53.
57. Wilson A, Henry DA. Meta-analysis. Part 2: Assessing the quality of published meta-analyses. Med J Aust 1992;156:173-87.